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Abstract. The present study evaluated the effectiveness of sildenafil citrate (SC) to improve placental and fetal growth 
in a diet-induced rabbit model of intrauterine growth restriction (IUGR). Pregnant rabbits were fed either ad libitum 
(Group C) or restricted to 50% of dietary requirements (Group R) or restricted and treated with SC (Group SC). The 
treatment with SC improved placental development by increasing vascularity and vessel hypertrophy in the decidua. The 
assessment of feto–placental haemodynamics showed higher resistance and pulsatility indices at the middle cerebral artery 
(MCA) in fetuses treated with SC when compared with Group R, which had increased systolic peak and time-averaged 
mean velocities at the MCA. Furthermore, fetuses in the SC group had significantly higher biparietal and thoracic 
diameters and longer crown–rump lengths than fetuses in Group R. Hence, the SC group had a reduced IUGR rate and a 
higher kit size at birth compared with Group R. In conclusion, SC may provide potential benefits in pregnancies with 
placental insufficiency and IUGR, partially counteracting the negative effects of food restriction on placental development 
and fetal growth. However, the present study also found evidence of a possible blood overflow in the brain that warrants 
further investigation.
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Introduction
The failure of fetuses to achieve their full growth potential is
known as intrauterine growth restriction (IUGR). Currently,
between 5 and 10% of human infants undergo IUGR (Nardozza
et al. 2012) and, as a consequence, are at greater risk of neonatal
health disorders (Marsˇa´l 2002) and late-onset diseases in
adulthood (Ross and Desai 2013). The aetiology of IUGR is
multifactorial and scarcely understood, but is thought to include
a combination of maternal, environmental, fetal and placental
factors negatively affecting fetal homeostasis (Sankaran and
Kyle 2009).
The intrauterine environmental conditions of the fetus are
regulated by the placenta. At present, more than 60% of IUGR
offspring in developed countries are linked to abnormal placen-
tal development or placental insufficiency (Ghidini 1996). Thus,
research has been focussed on devising preventive and thera-
peutic strategies for IUGR and, specifically, on developing
therapies to improve placental development and utero–placental
blood flow.An encouraging area of research is the stimulation of
the placental pro-angiogenic factors placental growth factor
(PIGF) and vascular endothelial growth factor (VEGF), which
are primarily driven by nitric oxide (NO) and its endothelial
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constitutive synthase (eNOS or NOS3). NO is a potent stimula-
tor of vasodilatation and angiogenesis during placental devel-
opment (Purcell et al. 1999) and decreased NO bioavailability is
recognised to be involved in the pathogenesis of IUGR (Serrano
et al. 2004). Based on this, a possible therapeutic strategy would
be the administration of sildenafil citrate (SC), a vasodilator
molecule that enhances NO concentrations by inhibiting phos-
phodiesterase-5 (PDE-5) activity (Chuang et al. 1998), which
may optimise placental function and, therefore, alleviate IUGR
in at-risk pregnancies. After preclinical studies, SC is being
tested inwomenwith promising results, improvingmaternal and
fetal blood flow velocimetry and fetal well being (Lacassie et al.
2004; Lin et al. 2012; Panda et al. 2014; Sun et al. 2014; Trapani
et al. 2015). Currently, several clinical trials are underway to
further test the usefulness and safety of SC treatments for IUGR
(Ganzevoort et al. 2014).
Research in human pregnancies is obviously limited by
ethical and practical limitations and necessitates the use of
animal models. Most studies of IUGR have been performed in
rodent models (Schroder 2003). However, the rabbit is an
emergent and complementary model for pregnancy studies
(Eixarch et al. 2009; Pu¨schel et al. 2010). The size of a rabbit
allows serial blood sampling and imaging and also shows more
similarities in metabolic, endocrine, placental and fetal features
to humans than rodents (Kobayashi et al. 2011; Fischer et al.
2012; Malassine´ et al. 2013). Specifically, the rabbit placenta is
haemodichorial, which is more physiologically similar to the
haemomonochorial human placenta than the haemotrichorial
placenta of rodents (Fischer et al. 2012). Haemodynamic
changes in the placenta during pregnancy in rabbits are also
comparable to those in humans (Fischer et al. 2012; Lecarpen-
tier et al. 2012), with high blood flow velocities in the umbilical
arteries resembling human values in the second trimester
(Polisca et al. 2010). Additionally, brain white-matter matura-
tion in rabbits occurs during the perinatal period, similarly to
humans, whilst in rodents this process occurs largely in the
postnatal period (Beaudoin et al. 2003; Derrick et al. 2009).
Different studies in rodentmodels have demonstrated that SC
administration during pregnancy prevents the production of
inflammatory cytokines, prevents fetal loss (Luna et al. 2015),
improves feto–placental blood flow (Stanley et al. 2012) and
increases fetal weight (Stanley et al. 2012; Dilworth et al. 2013).
However, most of the results were obtained post mortem and the
ontogeny of changes in feto–placental haemodynamics and
intrauterine growth are unknown.
Hence, the present study evaluated whether maternal SC
administration could improve or ameliorate diet-induced
defects in feto–placental development, haemodynamics and
offspring outcome seen in rabbits exposed to 50% food restric-
tion from Day 9 of pregnancy onwards, a model previously
developed in our laboratory (Lo´pez-Tello et al. 2015).
Materials and methods
Ethical approval
All experiments were carried out at the animal facilities of the
PolytechnicUniversity ofMadrid (UPM, Spain), whichmeet the
requirements of the European Union for scientific procedure
establishments, under project licence of the UPM Scientific
Ethic Committee. Animal manipulations were performed in
accordance with the Spanish policy for animal protection RD53/
2013, which complied with the European Union Directive about
the protection of animals used in experimentation.
Animals and management
The experiment involved 45 New ZealandCalifornia White
rabbits (Oryctolagus cuniculus). Females were previously arti-
ficially inseminated and during the trial the animals were kept in
individual cages under a constant photoperiod of 16 h light per
day. A temperature of 18–228C and a relative humidity of 60–
75% were maintained by a forced ventilation system, according
to the normal husbandry conditions for rabbits (Rebollar et al.
2012). All females had free access to water and were fed a diet
containing 16% crude protein, 37% crude fibre, 3.7% fat and
crude energy content of 2400 kcal kg1 (Nanta, Spain). Daily
food intake of dams was determined individually (2 weeks
before starting the experiment). Food intake was measured daily
by weighing the food and feeder at the beginning and at the end
of the adjustment period. The mean food intake of all dams was
187.0 11.0 g day1.
Experimental design
At Day 9 of pregnancy (term¼Day 31), females were randomly
distributed into three experimental groups. The first group was
fed ad libitum during the entire pregnancy and considered to be
the control group (Group C; n¼ 15), whilst the remaining dams
were restricted individually to 50% of their average daily food
intake until parturition. From Day 22 of pregnancy to delivery,
half of the restricted dams were treated daily with oral SC. This
was prepared by grinding Viagra tablets (100mg; Pfizer, USA;
5mg kg1 excluding excipients) and mixing in 1mL of baby
food (Hero Baby, Spain; Group SC, n¼ 15). The remaining
restricted dams received no other treatment andwere considered
as the untreated controls of food restriction (Group R, n¼ 15).
Day 22 was chosen because it corresponds to the beginning of
the period in pregnancy in which enlargement of the uterus
ceases, the somatic circulation rate decreases and the incidence
of IUGR is augmented due to the increase in the requirements of
the fetuses for oxygen and nutrients (Reynolds 1946; Lo´pez-
Tello et al. 2015). The SC dose used in this trial was adjusted
according to previous studies performed in rabbits and rats (Park
et al. 2004; Cauli et al. 2010) and it was administrated orally
with a syringe once per day (0900 hours) to ensure that each
animal received the adequate dose, avoiding any under- or over-
dosing. The use of a unique dose per day was based on the
protocols of Sa´nchez-Aparicio et al. (2008) in guinea pigs and
guidelines from the FDA Center for Drug Evaluation and
Research in pregnant rabbits (http://www.accessdata.fda.gov/
drugsatfda_docs/NDA/98/viagra/pharm_tox_pp_117_114.pdf,
verified 28 April 2016). Both control groups (C and R) also
received 1mL of baby food at the same time as treated dams to
avoid any possible confounding effect.
Four days after SC administration (Day 26 of pregnancy;
E84% of the total pregnancy), four females of each group were
randomly submitted to a Doppler evaluation. At Day 28 of
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pregnancy (E90% of the total pregnancy), 22 dams were killed
to study feto–placental morphology and the remaining females
were allowed to deliver, registering data from newborns.
Study of fetuses and placentas
The dams were sedated with 35mg kg1 ketamine (Imal-
gene1000; Merial, Spain) and then killed using an intravenous
bolus of barbiturate (30mg kg1; Dolethal; Vetoquinol, Spain).
A mid-ventral abdominal laparotomy was made to remove the
entire reproductive tract. Fetuses were dissected from their
extra-embryonicmembranes and considered as either: (1) viable
fetus (presented natural morphological features according to age
and bodyweight; see Fig. S1a, available as Supplementary
Material to this paper), (2) mummified or dead fetus (excluded
from trial as we could not determinate the exact time of death;
Fig. S1b) or (3) resorption (with atrophied fetal and maternal
placenta; Fig. S1c).
For the viable fetuses, placentas were immediately and
gently separated from the decidua (attached to the endometrium
and comprised of uninucleated and giant cells in a matrix of
collagen in which maternal blood passes to the implantation site
through spiral arteries; Samuel et al. 1975) and the labyrinth
(mainly composed of fetal and maternal capillaries and tropho-
blast responsible for nutrient and oxygen exchange; Fig. S1d ).
Both compartments were weighed and the length and thickness
measured using slide calipers (values were obtained by consid-
ering the average of three consecutive measurements). Follow-
ing this, fetuses were weighed and measured for crown–rump
length (CRL, maximum distance from crown to tail), biparietal
diameter (BPD, length from one parietal eminence to the other)
and transversal thoracic diameter (TD, length at the diaphragm
insertion). Fetuses were beheaded at the atlanto–occipital joint
and, after cranial opening andmedial laparotomy, fetal brain and
liver were removed and weighed.
A viable fetus was considered to have been exposed to IUGR
when its bodyweight was below the 10th percentile, assuming
the control group as our standard value. Afterwards, different
ratios were obtained by dividing fetal (head, brain and liver) and
placental structures (decidua and labyrinth zones) by fetal
weight. The weight of the brain relative to the liver was also
considered as an indicator of IUGR. Finally, in order to evaluate
fetal metabolic status, a total of 30 fetuses from each group were
randomly selected. Blood samples were obtained after decapi-
tation and placed in tubes with ethylenediamine tetraacetic acid
(EDTA), centrifuged at 1200g for 10min at 48C to obtain plasma
and immediately stored at 208C until analysis. Parameters
related to themetabolism of glucose and lipids (triglycerides and
cholesterol) were measured with a clinical chemistry analyser
(Saturno 300 plus; Crony Instruments, Italy) according to the
manufacturer’s instructions.
Placental histopathology
Sections of placentas and uteri adjacent to the ovary were col-
lected (n¼ 10 per group), fixed in 4% paraformaldehyde for
24 h and switched to 70% ethanol for histological evaluation.
Samples were embedded in paraffin, sectioned at 4-mm thick-
ness and stained with haematoxylin–eosin following routine
laboratory procedures. Sections were examined histologically
by a trained pathologist blinded for the experimental procedure.
Feto–placental haemodynamics
Ultrasound scanning was carried out with a Vivid-I ultrasound
machine equipped with a multi-frequency (8–12MHz) linear
array probe (General Electrics Ultraschall Deutschland GmbH,
Germany). In brief, fasted animals were shaved at the abdominal
area and gently restrained in dorsal recumbence, without anaes-
thesia to avoid any effect on heart rate and blood flow during the
observations. Females usually stayed calm and relaxed during
the procedure since theywere regularly handled by research staff.
A complete scan of the dam did not last more than 20min.
Measurements were taken from 48 fetuses (four fetuses from
each female in order to minimise individual effects).
Blood-flow parameters of umbilical cord arteries (UCA) and
middle cerebral arteries (MCA) were determined after identify-
ing the vessels with colour Doppler. The waveforms of three
consecutive cardiac cycles in each vessel were recorded, dis-
regarding views with angles of insonation between 20 and 608.
Measurements were obtained after the entire examination,
recording and including resistance index (RI), pulsatility index
(PI), systolic peak velocity (SPV), end diastolic velocity (EDV)
and time-averaged mean velocity (MV), measured at both UCA
and MCA.
Neonatal study
Twenty-three dams were allowed to deliver in order to study the
effects of food restriction and SC administration during preg-
nancy on the neonates. Immediately after birth, all the kits
(n¼ 251) were classified as viable newborns (n¼ 236) or still-
borns (n¼ 15). Bodyweight and morphometric parameters
(CRL, BPD and TD) were measured only in viable newborns.
A newborn was considered to have IUGR when its bodyweight
was below the 10th percentile assuming the control group at
birth as our standard value.
Statistical analysis
Statistical analyses were performed with Statistical Analysis
System Software (SAS Institute Inc. Cary, NC, USA). Effects of
undernutrition and sildenafil treatment on the morphological
parameters of fetuses, placentas and newborns and the haemo-
dynamic parameters of fetuseswere assessedbyone-wayanalysis
of variance (one-way ANOVA); t-test was performed to contrast
the differences between groups. The number of fetuses or kits per
dam was used as a covariate. Possible differences in IUGR rate
and number of placentas with histological findings were calcu-
lated by a x2 test. All data are reported as mean s.e.m. and
probabilities were considered to be significant at P, 0.05.
Results
Morphological study of fetuses and placentas
The number of total (C, 11.95 0.77; R, 12.70 0.70; SC,
12.75 0.75), viable (C, 11.55 0.78; R, 11.60 0.71; SC,
11.59 0.76) and mummified (C, 0.15 0.14; R, 0.22 0.19;
SC, 0.13 0.13) fetuses and resorptions (C, 0.25 0.20;
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R, 0.27 0.19; SC, 0.27 0.20) were similar among groups. All
the values for morphometric measurements were lower in
Group R than in Group C (P, 0.05; Table 1). Conversely, the
BPD of the SC group was higher than in Groups C and R
(P, 0.05), whilst the CRL was similar to Group C and greater
than Group R. For the SC group, the TDwas lower thanGroup C
but greater than Group R. Food restriction (Groups R and SC)
reduced theweight of fetuses aswell as theweight of head, body,
liver and brain when compared with Group C (P, 0.05).
However, SC administration was associated with an interme-
diate value of IUGR rate when compared with Groups C and R
(Table 1 and Fig. S2). The ratios of head and brain to fetal
weight (Table 1) were significantly higher in Groups R and SC
(P, 0.05), whilst the brain to liver weight ratio was only higher
in Group R (P, 0.05). In contrast, the ratio of liver to fetal
weight was higher only in Group SC (P, 0.05).
With regards to metabolic status, fetuses from Group SC
presented higher plasma glucose concentrations compared
with Groups C and R (104.23 6.72 vs 76.91 8.49 and
79.35 6.84mg dL1, respectively; P, 0.05). However, no
differences in plasma cholesterol (C, 85.17 4.22; R, 81.84
3.32; SC, 84.64 3.28mg dL1) or triglyceride concentra-
tions (C, 116.90 7.05; R, 116.84 5.70; SC, 112.01
5.87mg dL1) were found among groups.
Maternal food restriction was also found to be related to
changes in placental development in both the decidua and the
labyrinth compartment (Table 2). The decidua was significantly
thinner in Group R, whereas placentas in the group treated with
SC had similar values to Group C. On the other hand, there was a
trend for a thicker labyrinth in Group SC than in Group R
(P¼ 0.08). The food restriction in both SC andRgroups reduced
the length of decidua and labyrinth, but did not affect compart-
ment weight. Finally, the weight of the placenta relative to fetal
weight, total placental ratio, was significantly higher in
Group SC than in Group C (P, 0.05). The ratio between the
decidua and fetal weight for Group SC showed intermediate
values between Groups C and R, whilst the labyrinth to fetal
weight ratio was significantly higher in Group SC when com-
pared with the other two groups (P, 0.05).
Placental histopathology
Significant histological findings are summarised in Table 3 and
Fig. 1. Histological changes in the placental structure were
found in the junction zone and decidua region of both restricted
groups (R and SC). The junction zones of a high percentage of
placentas from Group R contained moderately increased
amounts of poorly cellular fibrous connective tissue that
extended multi-focally into the labyrinth and surrounds, and
replaced vascular channels with the collapse of the adjacent
labyrinth structure. Additionally, the decidua from the animals
of Group R was moderately thinned when compared with the C
and SC groups. On the other hand, there was a higher percentage
of labyrinth and decidua samples containing moderately to
markedly increased numbers of dilated small capillaries,
venules and arterioles in the SC group. Interestingly, these
placentas presented a higher number of andmore dilated arterial
sinuses compared with placentas from control and restricted
animals without treatment.
Feto–placental haemodynamics
The results obtained at Day 26 of pregnancy showed a trend for
higher RI (P¼ 0.06) and a significantly higher SPV (P, 0.05)
in the UCA in both restricted groups with respect to fetuses
from Group C (Table 4). There were significant effects of SC
treatment on the blood flow in the fetal MCA, with fetuses in
Table 1. Morphometric study of fetuses at Day 28 of pregnancy from dams fed ad libitum (C), restricted
diet (R) or restricted diet and treated with sildenafil citrate (SC)
Statistical analyses were performed by one-way ANOVA and t-test mean comparison test. IUGR rate defined as
those fetuses under 10th percentile of ad libitum control weights (32 g) estimated by a x2 test. Data represented as
mean s.e.m. a,b,cDifferent superscripts within a row indicate significant differences between groups; P, 0.05
Parameter C (n¼ 81) R (n¼ 94) SC (n¼ 77) P. f
Morphometric measurements
Biparietal diameter (cm) 1.76 0.02a 1.67 0.02b 1.82 0.02c 0.001
Crown–rump length (cm) 10.52 0.08a 9.95 0.07b 10.32 0.08a 0.001
Thoracic diameter (cm) 1.82 0.02a 1.63 0.02b 1.70 0.02c 0.001
Fetus weights
Total (g) 39.28 0.64a 33.91 0.59b 34.30 0.66b 0.001
Head (g) 9.46 0.15a 8.47 0.14b 8.67 0.16b 0.001
Body (g) 29.50 0.52a 25.34 0.49b 25.44 0.54b 0.001
Liver (g) 2.90 0.07a 2.52 0.07b 2.63 0.08b 0.001
Brain (g) 1.05 0.01a 0.99 0.01b 1.00 0.01b 0.001
Weight ratios
Head weight (%) 24.22 0.32a 25.36 0.30b 25.40 0.33b 0.015
Brain ratio (%) 2.74 0.05a 3.05 0.04b 2.94 0.05b 0.001
Liver ratio (%) 7.34 0.14a 7.32 0.13a 7.74 0.14b 0.035
Brain : liver ratio (%) 38.66 1.16a 43.65 1.09b 39.01 1.19a 0.002
IUGR rate (%) 9.87a 44.68b 29.87c 0.001
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Group SC showing higher RI and PI than those from the other
two groups (P, 0.05). SPV and MV measurements were also
higher in the SC group than for fetuses in Group C (P, 0.05).
Neonatal morphological study
Atparturition, no significant differences in the total number of kits
delivered (C, 11.62 0.88; R, 11.28 1.01; SC, 9.72 1.37),
newborns (C, 10.62 0.84; R, 10.71 0.92; SC, 9.28 1.25) or
stillborns (C, 1 0.62; R, 0.57 0.30; SC, 0.42 0.30) were
found.GroupChad thehighest values for averagebodyweight and
morphometric measurements of BPD, CRL and TD (P, 0.05),
whereas SC kits showed intermediate values between Groups C
and R for all morphometric parameters studied except fetal
weight. Food restriction significantly increased the rate of new-
born IUGR(P, 0.05;Table5 andFig. S3),whilst values obtained
from the group with SC administration were intermediate
between Groups C and R.
Discussion
The results of the present study in a rabbit model support the
usefulness of treatment with sildenafil citrate to alleviate states
of placental dysfunction and improve body size in fetuses
affected by IUGR.
In the present trial, sildenafil citrate therapy favoured pla-
cental growth and vascularisation, lowered IUGR incidence and
resulted in offspring with increased birth size (in terms of higher
values of crown–rump length and biparietal and thoracic dia-
meters). Our results support previous data showing thatmaternal
undernutrition during pregnancy or defects in placental devel-
opment have negative effects on fetal homeostasis and give way
to the appearance of IUGR (Lesage et al. 2001; Pardi et al. 2002;
Matsuoka et al. 2006). Herein we found that a 50% reduction in
maternal food intake in a rabbit model impaired placental
structural phenotype (reduced length of decidua and labyrinth
compartments) and led to placental pathology (such as atrophy
or fibrosis). In contrast, placentas from pregnancies treated with
sildenafil citrate showed significant changes when compared
with those in the restricted group at the labyrinth zone (higher
values of labyrinth ratio and absence of fibrosis process) and at
the decidua compartment (increase in thickness and significant
hyperplasia and hypertrophy of arterial sinuses). We can
hypothesise that these changes are related to two main factors.
First, it is known that sildenafil citrate acts as a potent angiogen-
esis stimulator (Pyriochou et al. 2007), increasing the growth of
new vessels at the labyrinth (which is supported by the histolo-
gical assessment, showing a higher number of small dilated
capillaries when compared with untreated placentas). Concom-
itantly, a recent study from Luna et al. (2015) also found slight
vasodilatation at the labyrinth zone in placentas of mice treated
with this therapy. Second, the myometrium and the decidua
vessels express high levels of PDE-5 (Buhimschi et al. 2004;
Coppage et al. 2005) and, in the case of the rabbit, the placenta
Table 3. Characteristic placental histology at Day 28 of pregnancy in
dams fed ad libitum (C), restricted diet (R) or restricted diet treatedwith
sildenafil citrate (SC)
Statistical analyses were performed by x2 test. Data represented as mean
s.e.m. a,bDifferent superscripts within a row indicate significant differences
between groups; P, 0.05 (number of placentas with findings compared
with the total number of samples)




10a (1/10) 50b (5/10) 0a (0/10) 0.009
Junctional zone
Fibrosis (%) 10a (1/10) 60b (6/10) 0a (0/10) 0.001
Increased
vascularity (%)
0a (0/10) 0a (0/10) 80b (8/10) 0.001
Decidual zone
Atrophy (%) 0a (0/10) 70b (7/10) 0a (0/10) 0.001
Hyperplastic
arterial sinuses (%)
0a (0/10) 0a (0/10) 80b (8/10) 0.001
Table 2. Placental dimensions obtained at Day 28 of pregnancy in dams fed ad libitum (C), restricted diet
(R) or restricted diet and treated with sildenafil citrate (SC)
Statistical analyses were performed by one-way ANOVA and t-test mean comparison test. Data represented as
mean s.e.m. IUGR rate estimated by a x2 test. a,bDifferent superscripts within a row indicate significant
differences between groups; P, 0.05
Parameter C (n¼ 81) R (n¼ 94) SC (n¼ 77) P. f
Total placental weight (g) 5.62 0.16 5.28 0.15 5.27 0.16 0.205
Total placental weight/fetal weight (%) 14.74 0.41a 15.57 0.37ab 16.01 0.40b 0.030
Decidual zone
Weight (g) 1.28 0.04 1.24 0.04 1.15 0.04 0.100
Length (cm) 3.65 0.09a 3.23 0.09b 3.36 0.10b 0.006
Thickness (cm) 0.32 0.02a 0.26 0.02b 0.35 0.02a 0.001
Decidua weight/fetal weight (%) 3.41 0.16a 3.88 0.15b 3.49 0.16a 0.038
Labyrinth zone
Weight (g) 3.93 0.14 3.64 0.13 3.8 0.14 0.323
Length (cm) 3.61 0.06a 3.27 0.05b 3.34 0.06b 0.001
Thickness (cm) 0.47 0.02 0.43 0.01 0.48 0.02 0.084
Labyrinth weight/fetal weight (%) 10.27 0.34a 10.62 0.31a 11.53 0.34b 0.029
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Fig. 1. Histological images of rabbit placenta at Day 28 of pregnancy in dams fed ad libitum (Group C), restricted diet (Group R) and restricted diet
treatedwith sildenafil citrate (GroupSC). (a, b, c) The three parts of the rabbit’s placenta (l, labyrinth; j, junctional zone and d, decidua) in each of the three
experimental groups. (d ) Group C, normal trophoblast (tb) proliferation at the labyrinth zone. (e) Group R, vascular channels collapsed with multifocal
areas of fibrosis (*) and mineralisation at the labyrinth zone. ( f ) Group SC, normal trophoblast proliferation at the labyrinth zone in a similar pattern to
Group C. (g) Group C, vascularisation at the junctional zone with normal trophoblast and syncytiotrophoblasts (stb). (h) Group R, focus of sclerosis (*) at
the junctional zone with inflammatory infiltrations (e) and decreased number of trophoblasts. (i) Group SC, junctional zone with syncytiotrophoblasts,
increased vasculaturewith congestion (c) and haemorrhagic foci. ( j) GroupC, normal limits of the deciduawith thrombi (t) mineral and inflammation (*).
(k) Group R, decidua with necrosis, fibrin and few vascular channels. (l) Group SC, decidua with numerous dilated vascular channels (vc).
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has a high expression level of NOS, especially NOS3 (Khan
et al. 2012), which may facilitate sildenafil citrate function.
Both processes would be expected to stimulate neoangiogenesis
and may also improve maternal blood flow to the placenta,
thereby facilitating nutrient and oxygen delivery to the fetus.
Consequently, fetal growthwas improved in terms of crown–
rump length and biparietal and thoracic diameters, at Day 28 and
at birth. These findings support previous results from Sa´nchez-
Aparicio et al. (2008) and Stanley et al. (2012). However, this
larger body size was not concomitant with increases in fetal
weight, supporting data from previous studies in rodent models
(Ramesar et al. 2010; George et al. 2013; Motta et al. 2015).
Notwithstanding, studies in sheep with 50% food restriction
(similar to our restriction) have shown that sildenafil citrate
treatment increased fetal weight by 14% (Satterfield et al. 2010).
Such disagreement may be related to differences in nutrient
partitioning between monotocous and polytocous species
(Fowden and Moore 2012), the capacity of the placenta to adapt
its phenotype or function to undernutrition and the length of
sildenafil citrate therapy (a total of 87 days, from Day 28 to
Day 115 of pregnancy, Satterfield et al. 2010).
A remarkable finding of this novel study using a rabbit model
comes from the results obtained by assessing the relative growth
of fetal organs with respect to fetal weight, which may set the
basis for future studies on the use of sildenafil citrate therapies
and its impact on fetal organs. Fetuses treated with sildenafil
citrate developed a proportionally larger liver with respect to the
other two groups. This observation is in line with results
obtained in rats (Pellicer et al. 2011). It is well known that from
early development the liver is vital for health and body physiol-
ogy. It participates in fat deposition (Godfrey et al. 2012),
regulates growth and metabolism by modulating hormones
and growth factors (Hellerstein and Munro 1994; Tchirikov
et al. 2002) and is responsible for gluconeogenesis (Burns et al.
1997), the latter of which could explain the high glucose level
found in the SC group. But, even more importantly, the liver can
also modulate blood distribution as it is the first organ to receive
blood from the placenta (Tchirikov et al. 2002) and, due to the
presence of the ductus venosus, may distribute blood towards
essential organs at the expense of less-essential organs (Cohn
et al. 1974; Jensen et al. 1991). As a result of alterations in the
liver, blood distribution may have changed, favouring develop-
mental adaptation in the fetus by selectively increasing blood
flow to vital organs like the brain (‘brain-sparing effect’).
The data obtained in the present study support the idea that
undernutrition early in pregnancy may affect vital organs
leading to disproportionate growth of the fetus (Bauer et al.
2003; Desai et al. 2007) and that the fetus can counteract this by
an innate mechanism of fetal cardiac output distribution
(Giussani 2011). In the present study, restricted fetuses showed
higher head and brain mass relative to bodyweight, which
suggests asymmetric growth retardation of the fetus, supporting
the idea of the ‘thrifty phenotype’ (Wells 2011). Also, these data
support previous studies in which the comparison of the brain
weight to liver weight ratio was associated with undernutrition
and dysmaturity (Anderson 1972; Camm et al. 2010). However,
Table 4. Feto–placental haemodynamics at Day 26 of pregnancy from dams fed ad libitum (C),
restricted diet (R) or restricted diet and treated with sildenafil citrate (SC)
Statistical analyses were performed by one-way ANOVA and t-test mean comparison test. Data
represented as mean s.e.m. a,bDifferent superscripts within a row indicate significant differences
between groups; P, 0.05
Parameter C (n¼ 16) R (n¼ 16) SC (n¼ 16) P. f
Umbilical cord arteries
Resistance index 0.70 0.02 0.77 0.01 0.77 0.05 0.066
Pulsatility index 1.20 0.05 1.25 0.04 1.28 0.05 0.468
Systolic peak velocity 33.20 4.05a 42.60 3.46b 43.90 3.35b 0.012
End diastolic velocity 8.00 0.86 10.30 1.16 10.30 1.15 0.336
Time-averaged mean velocity 20.60 2.37 26.40 2.25 27.10 2.17 0.137
Middle cerebral artery
Resistance index 0.60 0.02a 0.60 0.02a 0.70 0.02b 0.023
Pulsatility index 0.90 0.05a 0.90 0.05a 1.10 0.05b 0.013
Systolic peak velocity 17.10 2.21a 22.20 1.94b 26.30 2.02b 0.015
End diastolic velocity 6.50 0.63 8.30 0.78 7.70 0.46 0.165
Time-averaged mean velocity 11.80 1.40a 15.30 1.28b 17.00 1.13b 0.026
Table 5. Morphometric measurements of newborns from dams fed
ad libitum (C), restricted diet (R) or restricted diet and treated with
sildenafil citrate (SC)
Statistical analyses were performed by one-way ANOVA and t-test mean
comparison test. Data represented as mean s.e.m. IUGR rate defined as
those fetuses under 10th percentile of ad libitum control weights (37.9 g)
estimated by a x2 test. a,b,cDifferent superscripts within a row indicate
significant differences between groups; P, 0.05
Parameter C (n¼ 85) R (n¼ 75) SC (n¼ 76) P. f
Bodyweight (g) 55.23 1.11a 49.46 1.18b 47.80 1.19b 0.001
Biparietal
diameter (cm)
2.20 0.01a 2.08 0.01b 2.15 0.01c 0.001
Crown–rump
length (cm)
11.00 0.09a 10.20 0.09b 10.50 0.10c 0.001
Thoracic
diameter (cm)
2.40 0.02a 2.17 0.02b 2.28 0.02c 0.001
IUGR rate (%) 9.41a 38.66b 25.00c 0.001
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the results obtained by dividing these weights suggest that
therapywith sildenafil citrate could ameliorate this ratio. Anoth-
er finding in this study is that, although this brain-sparing effect
has been proposed to be stimulated by the hypoglycaemic status
in the restricted fetus (Giussani 2011), data obtained in this
rabbit model suggest that theremay be factors in addition to fetal
glycaemic status that contribute.
Assessment of blood flow by Doppler ultrasonography at
Day 26 of pregnancy showed that food restriction induced
changes in the haemodynamic patterns of the fetus. Those IUGR
fetuses exhibited a trend to increase the umbilical artery resis-
tance index and demonstrated a significant increase in the
systolic peak velocity, suggesting a deterioration of placental
function (Carr et al. 2012). These blood-flow changes could not
be rescued by sildenafil citrate, which is contrary to data from
previous studies (Dastjerdi et al. 2012; Lin et al. 2012; Stanley
et al. 2012; Trapani et al. 2015). As a consequence of the
placental dysfunction and reduction in oxygen levels, themiddle
cerebral artery in both restricted and sildenafil-treated fetuses
exhibited changes in the systolic mean velocity and therefore
increasedmean velocity values, which agrees with previous data
on themiddle cerebral artery of fetuses affected by IUGR (Hanif
et al. 2007; Mari et al. 2007).
Nevertheless, fetuses undergoing sildenafil citrate therapy
showed elevated values of pulsatility and resistance indexes, as
Dastjerdi et al. (2012) found in pregnant women, which may
suggest a certain grade of vasoconstriction (low indices reflects
redistribution of cardiac output to the brain; Mari et al. 2007). It
is known that cerebral neurons and vessels have high concen-
trations of PDE-5 (Kotera et al. 2000; Lin et al. 2006) and that
sildenafil citrate can cross the placenta (Pellicer et al. 2011).
Moreover, this therapy can increase brain cGMP levels (Zhang
et al. 2002) and cerebral blood flow (Li et al. 2007). Taken
together, these data suggest that fetuses from sildenafil-treated
mothers activate a protective mechanism in the middle cerebral
artery to counteract an excess in blood-flow supply that could
produce cerebral oedema and consequent adverse neurological
outcomes. However, these data should be interpreted with
caution, as the Doppler assessment was only performed once
during the pregnancy, and thus other possible changes in
gestation could not be determined in response to sildenafil
citrate in this study. Further studies are needed to determine
the possible risks of blood overflow in the fetal brain and also to
identify the mechanism by which the fetus is able to adapt its
cerebral arterial vascular tone; this process possibly depends on
the enhancement of nitric oxide abundance with sildenafil
citrate administration. Furthermore, elucidating whether these
haemodynamic and morphologic adaptations of the fetus can
have consequences in adult life should be the focus of future
investigations.
In summary, the results of the present study suggest that, in
rabbits, a 50% restriction of maternal food intake is a valid
model for inducing IUGR and placental insufficiency. Such
effects can be partially counteracted by the administration of
sildenafil citrate, since it improves reductions in perinatal body
size and modifies placental growth and vascularisation in the
labyrinth and decidua. Therefore, size of the newborns can be
partially improved. Thus, our study sets the basis of further
studies investigating the use of PDE-5 inhibitors to study organ
development and the programming of offspring growth and
postnatal homeostasis (in particular brain and liver function).
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